Bodenstedt Matthias
SEC CIK 1920545 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | CFO | 1.12M | $98.8K | $9.12M | 15 | 2023-04-05 | 2026-06-22 |
Most active insiders at MLTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BVF PARTNERS L P/IL | Dir, 10% | — | $62.96M |
| 2 | Cormorant Global Healthcare Master Fund, LP | Former 10% Owner | — | $46.87M |
| 3 | Santos da Silva Jorge | CEO, Dir | — | $8.73M |
| 4 | Reich Kristian | CSO | — | $8.14M |
| 5 | Bodenstedt Matthias | CFO | $98.8K | $3.20M |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-23 16:01 | 2026-06-22 | MLTX | MoonLake Immunotherapeutics | Bodenstedt Matthias | CFO | S - Sale | $22.04 | -39.1K | 1.12M | -3% | -$862.2K |
| MT | 2026-06-18 18:45 | 2026-06-17+ | MLTX | MoonLake Immunotherapeutics | Bodenstedt Matthias | CFO | S - Sale | $19.67 | -17.9K | 1.15M | -2% | -$351.6K |
| T | 2026-05-13 16:10 | 2026-05-11 | MLTX | MoonLake Immunotherapeutics | Bodenstedt Matthias | CFO | S - Sale | $20.02 | -13.7K | 1.17M | -1% | -$273.3K |
| T | 2026-04-16 16:10 | 2026-04-14 | MLTX | MoonLake Immunotherapeutics | Bodenstedt Matthias | CFO | S - Sale | $19.56 | -2,426 | 1.19M | -0.2% | -$47.5K |
| MT | 2026-04-10 18:06 | 2026-04-09+ | MLTX | MoonLake Immunotherapeutics | Bodenstedt Matthias | CFO | S - Sale | $18.95 | -87.8K | 1.19M | -7% | -$1.66M |
| 2026-01-09 | 2026-01-07 | MLTX | MoonLake Immunotherapeutics | Bodenstedt Matthias | CFO | A - Grant | $0.00 | +354.3K | 1.28M | +38% | $0 | |
| D | 2025-12-22 | 2025-12-19 | MLTX | MoonLake Immunotherapeutics | Bodenstedt Matthias | CFO | C - Cnv Deriv | — | +294.5K | 922.0K | +47% | — |
| D | 2025-12-22 | 2025-12-19 | MLTX | MoonLake Immunotherapeutics | Bodenstedt Matthias | CFO | D - Sale to Iss | — | -294.5K | 0 | -100% | — |
| 2025-10-09 | 2025-10-08 | MLTX | MoonLake Immunotherapeutics | Bodenstedt Matthias | CFO | P - Purchase | $9.09 | +10.9K | 627.5K | +2% | +$98.8K | |
| 2025-03-03 | 2025-02-27 | MLTX | MoonLake Immunotherapeutics | Bodenstedt Matthias | CFO | A - Grant | $0.00 | +95.8K | 616.7K | +18% | $0 | |
| M | 2023-12-21 | 2023-12-19+ | MLTX | MoonLake Immunotherapeutics | Bodenstedt Matthias | CFO | S - Sale | $59.17 | -100.0K | 520.9K | -16% | -$5.92M |
| D | 2023-10-03 | 2023-10-01 | MLTX | MoonLake Immunotherapeutics | Bodenstedt Matthias | CFO | D - Sale to Iss | — | -63.0K | 294.5K | -18% | — |
| D | 2023-10-03 | 2023-10-01 | MLTX | MoonLake Immunotherapeutics | Bodenstedt Matthias | CFO | C - Cnv Deriv | — | +63.0K | 620.9K | +11% | — |
| DM | 2023-04-07 | 2023-04-05 | MLTX | MoonLake Immunotherapeutics | Bodenstedt Matthias | CFO | D - Sale to Iss | — | -557.9K | 357.4K | -61% | — |
| DM | 2023-04-07 | 2023-04-05 | MLTX | MoonLake Immunotherapeutics | Bodenstedt Matthias | CFO | C - Cnv Deriv | — | +557.9K | 557.9K | New | — |
Purchase Sale Sale after option exercise All abbreviations